Status:
ENROLLING_BY_INVITATION
A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment
Lead Sponsor:
King's College London
Collaborating Sponsors:
Guy's and St Thomas' NHS Foundation Trust
Conditions:
Obese Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
New medications that work on gut hormones such as semaglutide (Wegovy) and tirzepatide (Mounjaro) are helping many people lose weight and are now recommended for treating obesity by the NHS. While the...
Detailed Description
Gut hormone-based therapies including the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy) and dual glucose-dependent insulinotropic polypeptide (GIP)/ GLP-1 receptor agonist Tirz...
Eligibility Criteria
Inclusion
- Adults aged \>18 years
- Living with obesity as diagnosed by healthcare professional.
- Referral to T3WMS at GSTT and currently on the service waiting list
- Eligible for GLP-1 receptor agonist (Wegovy) prescription
- Have an active MyChart account
- Have an email address
- Access to a digital device such as a smart phone, computer or tablet where you can access the internet
- Not following a meal replacement diet, for example soups / shakes
- Able to provide informed consent.
- Able to complete surveys in English.
Exclusion
- Adults aged \>18 years
- Living with obesity as diagnosed by healthcare professional.
- Referral to T3WMS at GSTT and currently on the service waiting list
- Eligible for GLP-1 receptor agonist (Wegovy) prescription
- Have an active MyChart account
- Have an email address
- Access to a digital device such as a smart phone, computer or tablet where you can access the internet
- Not following a meal replacement diet, for example soups / shakes
- Able to provide informed consent.
- Able to complete surveys in English.
- Not able to provide informed consent
- Not able to complete surveys in English
- Has an eating disorder
- Taking part in another research trial that involves dietary modification
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07194317
Start Date
September 1 2025
End Date
April 1 2026
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guy's and St Thomas' NHS Trust
London, Southwark, United Kingdom, SE1 9NH